Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience / Los inhibidores selectivos de la IL23 son en su mayoría efectivos y seguros en pacientes con psoriasis y fallo previo a tratamientos biológicos anti IL-17. Una experiencia de práctica clínica real a 52 semanas
Actas dermo-sifiliogr. (Ed. impr.)
; 114(4): 363-365, abr. 2023. tab, graf
Article
in English
| IBECS
| ID: ibc-219012
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Psoriasis
/
Antibodies, Monoclonal, Humanized
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Actas dermo-sifiliogr. (Ed. impr.)
Year:
2023
Document type:
Article
Institution/Affiliation country:
Hospital Universitario 12 de Octubre/Spain